Min Hao
Beijing University of Posts and Telecommunications(CN)Sun Yat-sen University(CN)Shanxi Medical University(CN)China University of Petroleum, Beijing(CN)Wenzhou Medical University(CN)Chengde Medical University(CN)Second Hospital of Shanxi Medical University(CN)Hanzhong People's Hospital(CN)Hanzhong Central Hospital(CN)Dongyang People's Hospital(CN)Geological Exploration Institute of Shandong Zhengyuan(CN)
Publications by Year
Research Areas
Cervical Cancer and HPV Research, Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Endometriosis Research and Treatment, Reproductive tract infections research
Most-Cited Works
- → Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial(2023)282 cited
- → Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆(2021)198 cited
- → Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer(2023)146 cited
- → Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women(2019)78 cited
- → Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial(2022)70 cited
- →